Attributions
Novel Gene-Therapy Approach for Glaucoma
Simon John, PhD
Columbia University
Co-Principal Investigators
Krish Kizhatil, PhD The Jackson LaboratorySummary
The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.